TD Asset Management’s Agilon Health AGL Stock Holding History

TD Asset Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,477	Closed	-$569K	–	1387
2024 Q2	$569K	Sell	3,477 -3,064	-47%	-$436K	﹤0.01%	1256
2024 Q1	$998K	Sell	6,541 -34,734	-84%	-$5.78M	﹤0.01%	1164
2023 Q4	$12.9M	Sell	41,275 -19,528	-32%	-$7.07M	0.01%	577
2023 Q3	$27M	Buy	60,803 +14,503	+31%	+$6.55M	0.03%	374
2023 Q2	$20.1M	Buy	46,300 +32,818	+243%	+$18.4M	0.02%	439
2023 Q1	$8M	Buy	13,482 +3,472	+35%	+$1.94M	0.01%	641
2022 Q4	$4.04M	Sell	10,010 -672	-6%	-$315K	0.01%	796
2022 Q3	$6.28M	Buy	10,682 +700	+7%	+$419K	0.01%	705
2022 Q2	$5.45M	Sell	9,982 -1,113	-10%	-$563K	0.01%	752
2022 Q1	$7.03M	Sell	11,095 -3,310	-23%	-$1.71M	0.01%	741
2021 Q4	$9.72M	Buy	14,405 +6,566	+84%	+$4M	0.01%	686
2021 Q3	$5.14M	Buy	7,839 +108	+1%	+$92.3K	0.01%	809
2021 Q2	$7.11M	Buy	+7,731	New	+$6.77M	0.01%	741

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TD Asset Management's AGL Position: Q3 2024 in Review

TD Asset Management sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 3,477 shares — an estimated $569K sold.

TD Asset Management first reported a position in AGL in Q2 2021 and held it in 13 quarters. The position peaked at $27M in Q3 2023. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

TD Asset Management reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
TD Asset Management sold 3,477 Agilon Health shares in Q3 2024, an estimated $569K.
TD Asset Management first reported a position in Agilon Health in Q2 2021 and held it in 13 quarters.
TD Asset Management's Agilon Health position peaked at $27M in Q3 2023.
209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on TD Asset Management's 13F filing for Q3 2024, filed 1 Nov 2024.